61.71 0.00 (0.00%)
After hours: 5:00PM EDT
|Bid||61.70 x 700|
|Ask||64.55 x 200|
|Day's Range||61.55 - 64.22|
|52 Week Range||54.66 - 82.80|
|PE Ratio (TTM)||10.76|
|Forward Dividend & Yield||1.85 (2.90%)|
|1y Target Est||N/A|
Let's put Cardinal Health (CAH) stock into this equation and find out if it is a good choice for value-oriented investors right now.
Companies with shares trading at a market price below what they are actually worth, such as Universal Forest Products and Cardinal Health, are deemed undervalued. There’s a few ways youRead More...
Starting in October 2017, Dentsply Sirona (XRAY) implemented a series of management changes with the aim of positioning the company as a stronger and more efficient organization and maintaining the company’s leadership position in dentistry. In October, the company accepted the resignations of Executive Chairman Bret W. Wise, CEO and Director Jeffrey T. Slovin, and President and COO (chief operating officer) Christopher T. Clark. Mark A. Thierer was appointed interim CEO, and Bob Size was appointed interim president and COO. Mark A. Thierer has around 30 years of healthcare industry experience and most recently served as the CEO of OptumRx.
Cardinal Health (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Shares of Cardinal Health Inc. said Friday it received notice that TRC Capital Corp. has launched a "mini-tender" to buy up to two million Cardinal shares at $65.85 a share. The tender offer ...
The Cleveland judge overseeing the mega-case of opioid lawsuits against drugmakers and distributors is suggesting a series of test trials to see which side is prevailing as settlement talks have reached an impasse. About 300 federal cases filed by cities, counties, states and Native American tribes have been consolidated before U.S. District Judge Dan Polster. The lawsuits say distributors, including Dublin-based Cardinal Health, failed in their duty to flag and prevent suspicious shipments.
Depomed (DEPO) has adopted a three-pronged business strategy with three key elements: maintain, build, and grow. Depomed aims to maintain its Nucynta franchise of pain products through the commercialization agreement it entered into with Collegium Pharmaceutical in December 2017. Under this agreement, Depomed granted commercialization rights for the Nucynta franchise of pain products to Collegium Pharmaceutical in the US.
U.S. Food and Drug Administrator Scott Gottlieb on Wednesday criticized drugmakers, pharmacy benefit managers and health insurers for "Kabuki drug-pricing constructs" that he said expose consumers to high out-of-pocket costs and discourage competition. Gottlieb delivered the remarks at an annual conference of health insurers in a speech largely aimed at promoting biosimilars, rival treatments that are as effective as the original but cheaper. Kabuki is a form of Japanese theater known for its dramatization and elaborate make-up of its performers.
Cardinal Health Inc. was named one of the top 70 large employers for advancement of women executives for the seventh year in a row from an offshoot of Working Mother magazine. Several others on the list, while not based in Central Ohio, have a significant local presence. The National Association for Female Executives, a trade group for professional women, annually surveys companies with more than 1,000 employees on female representation at all levels, but especially on boards, in C-suites and in managerial roles for profit-and-loss lines of business.
AmerisourceBergen (ABC) is one of the largest global pharmaceutical sourcing and distribution services companies. AmerisourceBergen delivers innovative programs and services designed to increase the effectiveness of the pharmaceutical supply chain in human and animal health. The company operates through two business segments—pharmaceutical distribution services and the other segment.
The healthcare sector has a higher prevalence of companies with sustainable competitive advantages compared to other sectors which implies it may continue generating robust excess returns. This means these healthcareRead More...
The federal government, backing litigation by states and cities, will seek reimbursement from major drug companies and distributors to recover costs it has borne from the opioid epidemic, the U.S. Justice Department said on Tuesday. Attorney General Jeff Sessions said Washington would side with plaintiffs in the litigation that accuses the drug makers of deceptively marketing opioids and alleges that distributors ignored red flags indicating the painkillers were being diverted for improper uses.
WASHINGTON (AP) — The Justice Department said Tuesday it will support local officials in hundreds of lawsuits against manufacturers and distributors of powerful opioid painkillers that are fueling the nation's drug abuse crisis.
AmerisourceBergen must enact sweeping reforms that address its role in the opioid crisis, says Teamsters' Treasurer Ken Hall.
Ohio Attorney General Mike DeWine has sued Cardinal Health Inc. – the state's largest publicly traded company – and three other pharmaceutical distributors in the latest of hundreds of lawsuits accusing the drug industry of fueling the opioid addiction epidemic. DeWine filed his complaint Monday in Madison County Common Pleas Court, pursuing a separate strategy from states and municipalities that have had their cases consolidated in federal court in Cleveland. Ohio also is suing the distributors apart from manufacturers, where other cases have lumped them together.
Cardinal Health Inc. is closing a pharmaceutical packaging center and a separate distribution warehouse in Zanesville, cutting 101 jobs, following an efficiency review. The facilities will close in April, the Dublin health care distributor said in a notice this week to the Ohio Department of Job and Family Services. "We continually work to optimize efficiencies of our operations and, so, as a result, have made the difficult decision to close our Zanesville location," the company said in a statement.
Kentucky's attorney general on Monday filed a lawsuit against drug distributor Cardinal Health Inc , accusing it of contributing to the opioid epidemic by failing to halt or report suspiciously large or frequent orders by pharmacies of prescription painkillers. Attorney General Andy Beshear in the lawsuit accused Cardinal of unfair, misleading and deceptive business practices that he said led to the excessive distribution of opioids in Kentucky. The lawsuit alleged that Dublin, Ohio-based Cardinal Health, one of the country's largest wholesale drug distributors, ignored red flags that prescription opioids were being diverted for illegal uses, allowing it to profit in the process.